Loading clinical trials...
Loading clinical trials...
Our hypothesis is that patients receiving therapy based on their baseline tumor ERCC1 levels and EGFR mutations would attain better disease free survival rates than patients in the control arm receivi...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Intergroupe Francophone de Cancerologie Thoracique
NCT06855771 · Carcinoma, Non-Small-Cell Lung
NCT06758401 · Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, and more
NCT06120140 · Carcinoma, Non-Small-Cell Lung
NCT06667908 · Carcinoma, Non-Small-Cell Lung
NCT04165798 · Carcinoma, Non-Small-Cell Lung
Centre Hospitalier
Aix-en-Provence
Clinique de L'Europe
Amiens
Angers - CHU
Angers
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions